#mucosal — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #mucosal, aggregated by home.social.
-
https://www.europesays.com/africa/170030/ Drug Carriers Market in Nigeria | Report – IndexBox #AnalyticalCharacterization(DLS #BiopharmaMarketReport #CrossingBiologicalBarriers(BBB #CryoEM) #DrugCarriers #forecast #LongActingInjectables #MarketAnalysis #MicrofluidicsForNanoparticleSynthesis #MRNA/vaccineDelivery #mucosal) #Nigeria #NTA #StimuliResponsiveReleaseMechanisms #SurfaceFunctionalization/ligandConjugation #TargetedCancerTherapy
-
Broad #protection against #Influenza A Viruses via an adjuvant-free #mucosal microparticle #vaccine with conserved CD8/CD4 bispecific peptides, https://etidiohnew.blogspot.com/2026/04/broad-protection-against-influenza.html
-
Broad #protection against #Influenza A Viruses via an adjuvant-free #mucosal microparticle #vaccine with conserved CD8/CD4 bispecific peptides, https://etidiohnew.blogspot.com/2026/04/broad-protection-against-influenza.html
-
Broad #protection against #Influenza A Viruses via an adjuvant-free #mucosal microparticle #vaccine with conserved CD8/CD4 bispecific peptides, https://etidiohnew.blogspot.com/2026/04/broad-protection-against-influenza.html
-
Broad #protection against #Influenza A Viruses via an adjuvant-free #mucosal microparticle #vaccine with conserved CD8/CD4 bispecific peptides, https://etidiohnew.blogspot.com/2026/04/broad-protection-against-influenza.html
-
Broad #protection against #Influenza A Viruses via an adjuvant-free #mucosal microparticle #vaccine with conserved CD8/CD4 bispecific peptides, https://etidiohnew.blogspot.com/2026/04/broad-protection-against-influenza.html
-
Dual-Route #H5N1 #Vaccination Induces Systemic and #Mucosal #Immunity in Murine and Bovine Models, https://etidiohnew.blogspot.com/2025/09/dual-route-h5n1-vaccination-induces.html
-
Dual-Route #H5N1 #Vaccination Induces Systemic and #Mucosal #Immunity in Murine and Bovine Models, https://etidiohnew.blogspot.com/2025/09/dual-route-h5n1-vaccination-induces.html
-
Dual-Route #H5N1 #Vaccination Induces Systemic and #Mucosal #Immunity in Murine and Bovine Models, https://etidiohnew.blogspot.com/2025/09/dual-route-h5n1-vaccination-induces.html
-
Dual-Route #H5N1 #Vaccination Induces Systemic and #Mucosal #Immunity in Murine and Bovine Models, https://etidiohnew.blogspot.com/2025/09/dual-route-h5n1-vaccination-induces.html
-
Dual-Route #H5N1 #Vaccination Induces Systemic and #Mucosal #Immunity in Murine and Bovine Models, https://etidiohnew.blogspot.com/2025/09/dual-route-h5n1-vaccination-induces.html
-
Chapter One - #Mucosal #Sudan virus #infection results in a lethal disease in #ferrets with previous #Lloviu virus infection not providing cross-protection, https://etidiohnew.blogspot.com/2025/07/chapter-one-mucosal-sudan-virus.html
-
Chapter One - #Mucosal #Sudan virus #infection results in a lethal disease in #ferrets with previous #Lloviu virus infection not providing cross-protection, https://etidiohnew.blogspot.com/2025/07/chapter-one-mucosal-sudan-virus.html
-
Chapter One - #Mucosal #Sudan virus #infection results in a lethal disease in #ferrets with previous #Lloviu virus infection not providing cross-protection, https://etidiohnew.blogspot.com/2025/07/chapter-one-mucosal-sudan-virus.html
-
Chapter One - #Mucosal #Sudan virus #infection results in a lethal disease in #ferrets with previous #Lloviu virus infection not providing cross-protection, https://etidiohnew.blogspot.com/2025/07/chapter-one-mucosal-sudan-virus.html
-
Chapter One - #Mucosal #Sudan virus #infection results in a lethal disease in #ferrets with previous #Lloviu virus infection not providing cross-protection, https://etidiohnew.blogspot.com/2025/07/chapter-one-mucosal-sudan-virus.html
-
A trivalent #mucosal #vaccine encoding phylogenetically inferred ancestral #RBD #sequences confers pan- #Sarbecovirus #protection in mice https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00403-7?rss=yes
Case et al. use ancestral phylogenetic reconstructions of Sarbecovirus sequences to generate a pan-Sarbecovirus vaccine. In mice, vaccine confers protection vs all tested Sarbecoviruses, including #SARS-CoV, multiple SARS-CoV-2 #variants, & pre-emergent Sarbecovirus strains.
-
A trivalent #mucosal #vaccine encoding phylogenetically inferred ancestral #RBD #sequences confers pan- #Sarbecovirus #protection in mice https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00403-7?rss=yes
Case et al. use ancestral phylogenetic reconstructions of Sarbecovirus sequences to generate a pan-Sarbecovirus vaccine. In mice, vaccine confers protection vs all tested Sarbecoviruses, including #SARS-CoV, multiple SARS-CoV-2 #variants, & pre-emergent Sarbecovirus strains.
-
A trivalent #mucosal #vaccine encoding phylogenetically inferred ancestral #RBD #sequences confers pan- #Sarbecovirus #protection in mice https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00403-7?rss=yes
Case et al. use ancestral phylogenetic reconstructions of Sarbecovirus sequences to generate a pan-Sarbecovirus vaccine. In mice, vaccine confers protection vs all tested Sarbecoviruses, including #SARS-CoV, multiple SARS-CoV-2 #variants, & pre-emergent Sarbecovirus strains.
-
A trivalent #mucosal #vaccine encoding phylogenetically inferred ancestral #RBD #sequences confers pan- #Sarbecovirus #protection in mice https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00403-7?rss=yes
Case et al. use ancestral phylogenetic reconstructions of Sarbecovirus sequences to generate a pan-Sarbecovirus vaccine. In mice, vaccine confers protection vs all tested Sarbecoviruses, including #SARS-CoV, multiple SARS-CoV-2 #variants, & pre-emergent Sarbecovirus strains.
-
A trivalent #mucosal #vaccine encoding phylogenetically inferred ancestral #RBD #sequences confers pan- #Sarbecovirus #protection in mice https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00403-7?rss=yes
Case et al. use ancestral phylogenetic reconstructions of Sarbecovirus sequences to generate a pan-Sarbecovirus vaccine. In mice, vaccine confers protection vs all tested Sarbecoviruses, including #SARS-CoV, multiple SARS-CoV-2 #variants, & pre-emergent Sarbecovirus strains.
-
#Intranasal M2SR (#M2-deficient Single Replication) #Influenza #Vaccine Induces Broadly Reactive #Mucosal #Antibody Production in Adults, J Infect Dis.: https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiae361/7714804?redirectedFrom=fulltext&utm_source=advanceaccess&utm_campaign=jid&utm_medium=email
These data suggest that M2SR induces broadly cross-reactive mucosal immune responses which may provide better protection against drifted and newly emerging influenza strains.
-
#Intranasal M2SR (#M2-deficient Single Replication) #Influenza #Vaccine Induces Broadly Reactive #Mucosal #Antibody Production in Adults, J Infect Dis.: https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiae361/7714804?redirectedFrom=fulltext&utm_source=advanceaccess&utm_campaign=jid&utm_medium=email
These data suggest that M2SR induces broadly cross-reactive mucosal immune responses which may provide better protection against drifted and newly emerging influenza strains.
-
#Intranasal M2SR (#M2-deficient Single Replication) #Influenza #Vaccine Induces Broadly Reactive #Mucosal #Antibody Production in Adults, J Infect Dis.: https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiae361/7714804?redirectedFrom=fulltext&utm_source=advanceaccess&utm_campaign=jid&utm_medium=email
These data suggest that M2SR induces broadly cross-reactive mucosal immune responses which may provide better protection against drifted and newly emerging influenza strains.
-
#Intranasal M2SR (#M2-deficient Single Replication) #Influenza #Vaccine Induces Broadly Reactive #Mucosal #Antibody Production in Adults, J Infect Dis.: https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiae361/7714804?redirectedFrom=fulltext&utm_source=advanceaccess&utm_campaign=jid&utm_medium=email
These data suggest that M2SR induces broadly cross-reactive mucosal immune responses which may provide better protection against drifted and newly emerging influenza strains.
-
#Intranasal M2SR (#M2-deficient Single Replication) #Influenza #Vaccine Induces Broadly Reactive #Mucosal #Antibody Production in Adults, J Infect Dis.: https://academic.oup.com/jid/advance-article-abstract/doi/10.1093/infdis/jiae361/7714804?redirectedFrom=fulltext&utm_source=advanceaccess&utm_campaign=jid&utm_medium=email
These data suggest that M2SR induces broadly cross-reactive mucosal immune responses which may provide better protection against drifted and newly emerging influenza strains.
-
Hier habe ich alle meine recherchierten Quellen zu #StreptococcusSalivarius #K12 gegen #Corona zusammengetragen:
https://pastebin.hot-chilli.net/?0b3ce182e423df09#4kFQvggKB9pudVE2bSCRXZ4sgHSuviMxvGAMcd75xw6b #Covid #SARSCoV2 #S_Salivarius #mucosal #Schleimhautimmunität
-
Hier habe ich alle meine recherchierten Quellen zu #StreptococcusSalivarius #K12 gegen #Corona zusammengetragen:
https://pastebin.hot-chilli.net/?0b3ce182e423df09#4kFQvggKB9pudVE2bSCRXZ4sgHSuviMxvGAMcd75xw6b #Covid #SARSCoV2 #S_Salivarius #mucosal #Schleimhautimmunität
-
Hier habe ich alle meine recherchierten Quellen zu #StreptococcusSalivarius #K12 gegen #Corona zusammengetragen:
https://pastebin.hot-chilli.net/?0b3ce182e423df09#4kFQvggKB9pudVE2bSCRXZ4sgHSuviMxvGAMcd75xw6b #Covid #SARSCoV2 #S_Salivarius #mucosal #Schleimhautimmunität
-
Hier habe ich alle meine recherchierten Quellen zu #StreptococcusSalivarius #K12 gegen #Corona zusammengetragen:
https://pastebin.hot-chilli.net/?0b3ce182e423df09#4kFQvggKB9pudVE2bSCRXZ4sgHSuviMxvGAMcd75xw6b #Covid #SARSCoV2 #S_Salivarius #mucosal #Schleimhautimmunität
-
Hier habe ich alle meine recherchierten Quellen zu #StreptococcusSalivarius #K12 gegen #Corona zusammengetragen:
https://pastebin.hot-chilli.net/?0b3ce182e423df09#4kFQvggKB9pudVE2bSCRXZ4sgHSuviMxvGAMcd75xw6b #Covid #SARSCoV2 #S_Salivarius #mucosal #Schleimhautimmunität
-
Respiratory #mucosal immune #memory to #SARS-CoV-2 after #infection and #vaccination, Nat Commun.: https://www.nature.com/articles/s41467-023-42433-w #research #vaccines #covid19 #immunity
-
Respiratory #mucosal immune #memory to #SARS-CoV-2 after #infection and #vaccination, Nat Commun.: https://www.nature.com/articles/s41467-023-42433-w #research #vaccines #covid19 #immunity
-
Respiratory #mucosal immune #memory to #SARS-CoV-2 after #infection and #vaccination, Nat Commun.: https://www.nature.com/articles/s41467-023-42433-w #research #vaccines #covid19 #immunity
-
Respiratory #mucosal immune #memory to #SARS-CoV-2 after #infection and #vaccination, Nat Commun.: https://www.nature.com/articles/s41467-023-42433-w #research #vaccines #covid19 #immunity
-
Respiratory #mucosal immune #memory to #SARS-CoV-2 after #infection and #vaccination, Nat Commun.: https://www.nature.com/articles/s41467-023-42433-w #research #vaccines #covid19 #immunity
-
#Mucosal and #Serum #Antibodies 3 Weeks after Symptomatic #BA286 #Infection, October 26, 2023, N Engl J Med 2023; 389:1626-1628,
DOI: 10.1056/NEJMc2310347 #covid19 #SARS_COV_2 #research #immunity -
#Mucosal and #Serum #Antibodies 3 Weeks after Symptomatic #BA286 #Infection, October 26, 2023, N Engl J Med 2023; 389:1626-1628,
DOI: 10.1056/NEJMc2310347 #covid19 #SARS_COV_2 #research #immunity -
#Mucosal and #Serum #Antibodies 3 Weeks after Symptomatic #BA286 #Infection, October 26, 2023, N Engl J Med 2023; 389:1626-1628,
DOI: 10.1056/NEJMc2310347 #covid19 #SARS_COV_2 #research #immunity -
#Mucosal and #Serum #Antibodies 3 Weeks after Symptomatic #BA286 #Infection, October 26, 2023, N Engl J Med 2023; 389:1626-1628,
DOI: 10.1056/NEJMc2310347 #covid19 #SARS_COV_2 #research #immunity -
#Mucosal and #Serum #Antibodies 3 Weeks after Symptomatic #BA286 #Infection, October 26, 2023, N Engl J Med 2023; 389:1626-1628,
DOI: 10.1056/NEJMc2310347 #covid19 #SARS_COV_2 #research #immunity -
Promises and challenges of #mucosal #COVID19 vaccines
"Several mucosal vaccines are currently being developed with the aim of inducing long-lasting protective immune responses at the mucosal sites where #SARSCoV2 infection begins"
via @AlexPed
https://www.sciencedirect.com/science/article/pii/S0264410X23003961?dgcid=rss_sd_all
-
Promises and challenges of #mucosal #COVID19 vaccines
"Several mucosal vaccines are currently being developed with the aim of inducing long-lasting protective immune responses at the mucosal sites where #SARSCoV2 infection begins"
via @AlexPed
https://www.sciencedirect.com/science/article/pii/S0264410X23003961?dgcid=rss_sd_all
-
Promises and challenges of #mucosal #COVID19 vaccines
"Several mucosal vaccines are currently being developed with the aim of inducing long-lasting protective immune responses at the mucosal sites where #SARSCoV2 infection begins"
via @AlexPed
https://www.sciencedirect.com/science/article/pii/S0264410X23003961?dgcid=rss_sd_all
-
Promises and challenges of #mucosal #COVID19 vaccines
"Several mucosal vaccines are currently being developed with the aim of inducing long-lasting protective immune responses at the mucosal sites where #SARSCoV2 infection begins"
via @AlexPed
https://www.sciencedirect.com/science/article/pii/S0264410X23003961?dgcid=rss_sd_all
-
#Researchers have developed an #inhalable powder that could protect #lungs and airways from #viral invasion by reinforcing the body’s own #mucosal layer. The powder, called Spherical #Hydrogel Inhalation for Enhanced Lung Defense, or #SHIELD
#FLU #Covid19 #Virology #Biology #Engineering #Medical #sflorg
https://www.sflorg.com/2023/02/vi02092302.html -
#Researchers have developed an #inhalable powder that could protect #lungs and airways from #viral invasion by reinforcing the body’s own #mucosal layer. The powder, called Spherical #Hydrogel Inhalation for Enhanced Lung Defense, or #SHIELD
#FLU #Covid19 #Virology #Biology #Engineering #Medical #sflorg
https://www.sflorg.com/2023/02/vi02092302.html -
#Researchers have developed an #inhalable powder that could protect #lungs and airways from #viral invasion by reinforcing the body’s own #mucosal layer. The powder, called Spherical #Hydrogel Inhalation for Enhanced Lung Defense, or #SHIELD
#FLU #Covid19 #Virology #Biology #Engineering #Medical #sflorg
https://www.sflorg.com/2023/02/vi02092302.html
